These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22125206)

  • 1. [The endogenous cardioprotection during reperfusion in acute myocardial infarction].
    Zalewski J; Nessler J
    Kardiol Pol; 2011; 69 Suppl 3():67-74. PubMed ID: 22125206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Endogenous cardioprotective mechanisms - what is it about and how does it work?].
    Beręsewicz A
    Kardiol Pol; 2011; 69 Suppl 3():59-66. PubMed ID: 22125205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postconditioning: from the bench to bedside.
    Cour M; Gomez L; Mewton N; Ovize M; Argaud L
    J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):117-30. PubMed ID: 20938041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed postconditioning in the mouse heart in vivo.
    Roubille F; Franck-Miclo A; Covinhes A; Lafont C; Cransac F; Combes S; Vincent A; Fontanaud P; Sportouch-Dukhan C; Redt-Clouet C; Nargeot J; Piot C; Barrère-Lemaire S
    Circulation; 2011 Sep; 124(12):1330-6. PubMed ID: 21875909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Reperfusion and postconditioning in acute ST segment elevation myocardial infarction. A new paradigm for the treatment of acute myocardial infarction. From bench to bedside?].
    Lupi Herrera E; Gaspar J; González Pacheco H; Martínez Sánchez C; Pastelín Hernández G; Luna Ortiz P; Chávez Cosio E
    Arch Cardiol Mex; 2006; 76 Suppl 4():S76-101. PubMed ID: 17469337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The reduction of infarct size--forty years of research.
    Ferreira R
    Rev Port Cardiol; 2010 Jun; 29(6):1037-53. PubMed ID: 20964114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient metabolic alkalosis during early reperfusion abolishes helium preconditioning against myocardial infarction: restoration of cardioprotection by cyclosporin A in rabbits.
    Pagel PS; Krolikowski JG
    Anesth Analg; 2009 Apr; 108(4):1076-82. PubMed ID: 19299764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronary microembolization during early reperfusion: infarct extension, but protection by ischaemic postconditioning.
    Skyschally A; Walter B; Heusch G
    Eur Heart J; 2013 Nov; 34(42):3314-21. PubMed ID: 23242190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioprotection in the clinical setting.
    Ivanes F; Mewton N; Rioufol G; Piot C; Elbaz M; Revel D; Croisille P; Ovize M
    Cardiovasc Drugs Ther; 2010 Jun; 24(3):281-7. PubMed ID: 20589423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postconditioning: reduction of reperfusion-induced injury.
    Zhao ZQ; Vinten-Johansen J
    Cardiovasc Res; 2006 May; 70(2):200-11. PubMed ID: 16545349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention.
    Freixa X; Bellera N; Ortiz-Pérez JT; Jiménez M; Paré C; Bosch X; De Caralt TM; Betriu A; Masotti M
    Eur Heart J; 2012 Jan; 33(1):103-12. PubMed ID: 21846677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Myocardial Ischemia/Reperfusion Injury by Ischemic and Pharmacological Postconditioning.
    Heusch G
    Compr Physiol; 2015 Jul; 5(3):1123-45. PubMed ID: 26140711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efforts to reduce myocardial infarct size--the next step.
    Braunwald E
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):349-53. PubMed ID: 21821538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postconditioning--A new link in nature's armor against myocardial ischemia-reperfusion injury.
    Vinten-Johansen J; Zhao ZQ; Zatta AJ; Kin H; Halkos ME; Kerendi F
    Basic Res Cardiol; 2005 Jul; 100(4):295-310. PubMed ID: 15793629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postconditioning with levosimendan reduces the infarct size involving the PI3K pathway and KATP-channel activation but is independent of PDE-III inhibition.
    Hönisch A; Theuring N; Ebner B; Wagner C; Strasser RH; Weinbrenner C
    Basic Res Cardiol; 2010 Mar; 105(2):155-67. PubMed ID: 19842009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of mitochondrial permeability transition pore opening: translation to patients.
    Gomez L; Li B; Mewton N; Sanchez I; Piot C; Elbaz M; Ovize M
    Cardiovasc Res; 2009 Jul; 83(2):226-33. PubMed ID: 19221132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mechanism by which ischemic postconditioning reduces reperfusion arrhythmias in rats remains elusive.
    Dow J; Bhandari A; Kloner RA
    J Cardiovasc Pharmacol Ther; 2009 Jun; 14(2):99-103. PubMed ID: 19461101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-type natriuretic peptide at early reperfusion limits infarct size in the rat isolated heart.
    Burley DS; Baxter GF
    Basic Res Cardiol; 2007 Nov; 102(6):529-41. PubMed ID: 17896117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postconditioning inhibits mitochondrial permeability transition.
    Argaud L; Gateau-Roesch O; Raisky O; Loufouat J; Robert D; Ovize M
    Circulation; 2005 Jan; 111(2):194-7. PubMed ID: 15642769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.